Respiratory Syncytial Virus Infections
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Update: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study [Phase 3]
A Phase 3 extension and crossover vaccination study evaluating immune response and safety of an RSV vaccine in adults aged 60+ who participa…
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) [Phase 3]
Phase 3 trial results evaluating safety and immune response of an RSV vaccine in older adults (60+) and high-risk adults (50-59) with RSV-LR…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study [Phase 3]
This document reports an extension and crossover study of an RSV vaccine in adults 60 years and older who participated in a prior RSV trial;…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older [Phase 3]
Phase 3 study evaluating immune response, safety, and RSV-associated respiratory illness after RSV OA Vaccine in adults aged 60 and older ha…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above [Phase 3]
A Phase 3 trial evaluated the immune response and safety of an RSV vaccine in adults 50 years and older, given alone or together with a COVI…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults [Phase 3]
A Phase 3 study assessing the immune response, safety, and reactogenicity of the RSVPreF3 OA vaccine when co-administered with PCV20 in olde…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus [Phase 2]
Phase 2a trial evaluating orally administered ALS-008176 in adults hospitalized with respiratory syncytial virus has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model [Phase 2]
This document reports the completion of a Phase 2a trial evaluating ALS-008176 in a virus challenge model for Respiratory Syncytial Virus in…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of ALS-008176 in Infants Hospitalized With RSV [Phase 1]
A Phase 1 study evaluating ALS-008176 in infants hospitalized with Respiratory Syncytial Virus infections has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of oral Deuremidevir Hydrobromide for Suspension has been complete…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children [Phase 1]
Phase 1 trial results evaluating the safety and immunogenicity of the RSV D46cpΔM2-2 vaccine in RSV-seropositive children and RSV-seronegati…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers [Phase 3]
This Phase 3 double-blind trial of an RSV maternal unadjuvanted vaccine in pregnant women and their infants was terminated, and results were…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above [Phase 3]
Phase 3 study assessing safety and immune response of an RSV vaccine in adults aged 50-59 (including at higher risk for RSV lower respirator…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants [Phase 1]
Pfizer completed a Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of Sisunatovir in healthy adult male participant…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections [Phase 3]
Phase 3 trial investigating inhaled human interferon α1b solution for respiratory syncytial virus infections in children is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above [Phase 3]
Phase 3 study evaluating the immune response and safety of a respiratory syncytial virus vaccine given alone or co-administered with an adju…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: A Dose Finding Study of VN-0200 [Phase 2]
Phase 2 dose-finding trial of VN-0200 for respiratory syncytial virus infections has been completed.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY) [Phase 3]
Phase 3 MELODY trial evaluating MEDI8897 for prevention of medically attended lower respiratory tract infections due to RSV in healthy late …
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Viral Inhibition in Children for Treatment of RSV [Phase 2]
Phase 2 trial update on viral inhibition for respiratory syncytial virus infections in children; study completed.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: A Study of AK0529 in Chinese Infants Hospitalized With RSV [Phase 3]
Phase 3 trial update for AK0529 in Chinese infants hospitalized with Respiratory Syncytial Virus infections has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers [Phase 3]
Phase 3 study of an unadjuvanted RSV maternal vaccine in high-risk pregnant women and infants born to vaccinated mothers was terminated; res…
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. [Phase 3]
A Phase III trial evaluating lot-to-lot consistency, immune response, and safety of GSK's RSV maternal vaccine administered alone or with in…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children [Phase 2, Phase 3]
Clinical trial update for MEDI8897 evaluating safety for prevention of medically attended RSV LRTI in high-risk children; completed phases 2…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance [NA]
A completed clinical trial studying outcomes and events of interest in pregnant women, neonates, and infants, with RSV surveillance data; re…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) [Phase 2]
Phase 2 study of JNJ-53718678 in adults and adolescents with RSV infection after hematopoietic stem cell transplantation was terminated. Res…